SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-101652
Filing Date
2024-04-19
Accepted
2024-04-19 07:35:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d785693ddefa14a.htm DEFA14A 10865
2 GRAPHIC g785693g01b01.jpg GRAPHIC 426382
3 GRAPHIC g785693g02b02.jpg GRAPHIC 286099
  Complete submission text file 0001193125-24-101652.txt   993322
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38529 | Film No.: 24855624
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)